SCHEMBL8769050

SCHEMBL8769050

O=C(N/N=C/c1cccc(/C=N/NC(=O)c2ccc(-n3cccc3)cc2)c1)c1ccc(-n2cccc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.72
MAPT P10636 4/20 0.72
ALDH1A1 P00352 2/20 0.67
KDM4E B2RXH2 2/20 0.67
GAA P10253 1/20 0.67
KMT2A Q03164 4/20 0.64
MEN1 O00255 3/20 0.64
RAB9A P51151 6/20 0.59
TDP1 Q9NUW8 2/20 0.59
PLEC Q15149 1/20 0.59
CTDSP1 Q9GZU7 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.55
NPC1 O15118 3/20 0.55
CYP2D6 P10635 1/20 0.53
LMNA P02545 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
DUSP3 P51452 1/20 0.53
PTPN5 P54829 1/20 0.53
PTPN11 Q06124 1/20 0.53
CYP1A2 P05177 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12937846 0.88 POLB (0.70) POLBMAPTALDH1A1KDM4EGAA
SCHEMBL8767400 0.85 CA12 (0.68) POLBMAPTALDH1A1KDM4EGAA
SCHEMBL8769257 0.81 CA2 (0.65) POLBMAPTALDH1A1KDM4EKMT2A
SCHEMBL8767795 0.81 HDAC3 (0.72) POLBMAPTALDH1A1KDM4EGAA
SCHEMBL13569015 0.80 TDP1 (0.65) POLBMAPTKDM4EKMT2AMEN1
SCHEMBL8768854 0.79 ALDH1A1 (0.74) POLBMAPTALDH1A1KDM4EGAA
SCHEMBL8771684 0.78 RAB9A (0.85) POLBMAPTALDH1A1KDM4EKMT2A
SCHEMBL8769887 0.78 POLB (0.56) POLBMAPTALDH1A1KDM4EKMT2A
SCHEMBL8771811 0.77 TDP1 (0.62) POLBMAPTKDM4EKMT2AMEN1
SCHEMBL8771985 0.76 POLB (0.86) POLBMAPTALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9622991-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2017-04-18 US disclosed
US-9144557-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2015-09-29 US disclosed
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2015-09-10 US disclosed
US-20140243324-A1 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2014-08-28 US disclosed
US-20120295904-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2012-11-22 US disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243324-A1 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS HGF, EPOR, MPL POLB 3018/4885MAPT 4622/4885ALDH1A1 3228/4885
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF POLB 3224/4885MAPT 4411/4885ALDH1A1 2736/4885
US-20120295904-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF POLB 3224/4885MAPT 4411/4885ALDH1A1 2736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.